Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Treatment-Naive Proliferative Diabetic Retinopathy

NCT01746563 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT01746563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01746563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Treatment-Naive Proliferative Diabetic Retinopathy
Lead sponsor
University of Sao Paulo
Phase
Phase 1/2
Overall status
Completed
Start date
May 31, 2011
Completion date
August 31, 2012
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, diabetic angiopathies, diabetic retinopathy, eye diseases, retinal diseases, vascular diseases